PI3K Regulates Wild-type RAS Signaling to Confer Resistance to KRAS Inhibition
{{output}}
Despite the availability of RAS inhibitors and the dependence of >90% of pancreatic ductal adenocarcinomas (PDAC) on oncogenic KRAS mutations, resistance to KRAS inhibition remains a serious obstacle. We showed here that PI3K plays a major role in this resista... ...